Literature DB >> 27736061

The Antioxidant Additive Approach for Alzheimer's Disease Therapy: New Ferulic (Lipoic) Acid Plus Melatonin Modified Tacrines as Cholinesterases Inhibitors, Direct Antioxidants, and Nuclear Factor (Erythroid-Derived 2)-Like 2 Activators.

Mohamed Benchekroun1, Alejandro Romero2, Javier Egea3,4, Rafael León3,4, Patrycja Michalska3,4, Izaskun Buendía3,4, María Luisa Jimeno5, Daniel Jun6, Jana Janockova7, Vendula Sepsova6, Ondrej Soukup7, Oscar M Bautista-Aguilera1, Bernard Refouvelet1, Olivier Ouari8, José Marco-Contelles9, Lhassane Ismaili1.   

Abstract

Novel multifunctional tacrines for Alzheimer's disease were obtained by Ugi-reaction between ferulic (or lipoic acid), a melatonin-like isocyanide, formaldehyde, and tacrine derivatives, according to the antioxidant additive approach in order to modulate the oxidative stress as therapeutic strategy. Compound 5c has been identified as a promising permeable agent showing excellent antioxidant properties, strong cholinesterase inhibitory activity, less hepatotoxicity than tacrine, and the best neuroprotective capacity, being able to significantly activate the Nrf2 transcriptional pathway.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27736061     DOI: 10.1021/acs.jmedchem.6b01178

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  17 in total

1.  Antioxidants and Neuron-Astrocyte Interplay in Brain Physiology: Melatonin, a Neighbor to Rely on.

Authors:  Antonio Gonzalez
Journal:  Neurochem Res       Date:  2020-01-27       Impact factor: 3.996

Review 2.  Current and emerging therapeutic targets of alzheimer's disease for the design of multi-target directed ligands.

Authors:  Laura Blaikie; Graeme Kay; Paul Kong Thoo Lin
Journal:  Medchemcomm       Date:  2019-10-16       Impact factor: 3.597

3.  Synthesis of novel vanillin derivatives: novel multi-targeted scaffold ligands against Alzheimer's disease.

Authors:  Matteo Scipioni; Graeme Kay; Ian L Megson; Paul Kong Thoo Lin
Journal:  Medchemcomm       Date:  2019-04-08       Impact factor: 3.597

4.  Discovery of the first dual GSK3β inhibitor/Nrf2 inducer. A new multitarget therapeutic strategy for Alzheimer's disease.

Authors:  Isabel Gameiro; Patrycja Michalska; Giammarco Tenti; Ángel Cores; Izaskun Buendia; Ana I Rojo; Nikolaos D Georgakopoulos; Jesús M Hernández-Guijo; María Teresa Ramos; Geoffrey Wells; Manuela G López; Antonio Cuadrado; J Carlos Menéndez; Rafael León
Journal:  Sci Rep       Date:  2017-03-31       Impact factor: 4.379

5.  Triazolopyridopyrimidine: A New Scaffold for Dual-Target Small Molecules for Alzheimer's Disease Therapy.

Authors:  Lazhar Zribi; Irene Pachòn-Angona; Òscar M Bautista-Aguilera; Daniel Diez-Iriepa; José Marco-Contelles; Lhassane Ismaili; Isabel Iriepa; Fakher Chabchoub
Journal:  Molecules       Date:  2020-07-13       Impact factor: 4.411

6.  Evidence supporting oxidative stress in a moderately affected area of the brain in Alzheimer's disease.

Authors:  Priscilla Youssef; Belal Chami; Julia Lim; Terry Middleton; Greg T Sutherland; Paul K Witting
Journal:  Sci Rep       Date:  2018-08-01       Impact factor: 4.379

7.  Sulfur-containing therapeutics in the treatment of Alzheimer's disease.

Authors:  Haizhou Zhu; Venkateshwara Dronamraju; Wei Xie; Swati S More
Journal:  Med Chem Res       Date:  2021-01-15       Impact factor: 1.965

8.  Multifunctional Redox Modulators Protect Auditory, Visual, and Cognitive Function.

Authors:  Peter F Kador; Richard Salvi
Journal:  Antioxid Redox Signal       Date:  2021-08-13       Impact factor: 7.468

9.  Design, Synthesis of N-phenethyl Cinnamide Derivatives and Their Biological Activities for the Treatment of Alzheimer's Disease: Antioxidant, Beta-amyloid Disaggregating and Rescue Effects on Memory Loss.

Authors:  Tian Chai; Xiao-Bo Zhao; Wei-Feng Wang; Yin Qiang; Xiao-Yun Zhang; Jun-Li Yang
Journal:  Molecules       Date:  2018-10-16       Impact factor: 4.411

10.  Synthesis and biological assessment of KojoTacrines as new agents for Alzheimer's disease therapy.

Authors:  Youssef Dgachi; Hélène Martin; Rim Malek; Daniel Jun; Jana Janockova; Vendula Sepsova; Ondrej Soukup; Isabel Iriepa; Ignacio Moraleda; Emna Maalej; M Carmo Carreiras; Bernard Refouvelet; Fakher Chabchoub; José Marco-Contelles; Lhassane Ismaili
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.